Based on data from the past 90 days ending February 07, 2026, Akebia Therapeutics's three largest insider shareholders are Ceo And President John P. Butler (3.30Mn shares), Svp And Chief Medical Officer Steven Keith Burke (948.43K shares), Svp And Cfo And Cbo & Treasurer Erik Ostrowski (672.63K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| John P. Butler | Ceo And President | 3,297,794 | 04 Feb, 2026 |
| Steven Keith Burke | Svp And Chief Medical Officer | 948,432 | 04 Feb, 2026 |
| Erik Ostrowski | Svp And Cfo And Cbo & Treasurer | 672,635 | 04 Feb, 2026 |
| Michel Dahan | Svp And Chief Operating Officer | 672,092 | 14 May, 2024 |
| Nicole R. Hadas | Svp And Chief Legal Officer | 651,243 | 14 May, 2024 |
| Carolyn M. Rucci | Svp And Chief Legal Officer | 588,378 | 04 Feb, 2026 |
| Nicholas Grund | Chief Commercial Officer | 561,750 | 04 Feb, 2026 |
| Ellen Snow | Svp And Cfo And Treasurer | 519,300 | 02 Feb, 2024 |
| David A Spellman | Svp And Cfo And Treasurer | 446,483 | 18 May, 2023 |
| Richard C Malabre | Svp And Chief Accounting Officer | 299,390 | 04 Feb, 2026 |
| Violetta Cotreau | Svp And Chief Accounting Officer | 219,954 | 16 May, 2022 |
| Adrian Adams | 200,500 | 11 Jun, 2025 | |
| Dell Faulkingham | Svp And Cco | 173,841 | 02 Mar, 2022 |
| Michael W Rogers | 161,729 | 11 Jun, 2025 | |
| Cynthia Smith | 160,933 | 11 Jun, 2025 | |
| Steven C Gilman | 152,830 | 11 Jun, 2025 | |
| Myles Wolf | 133,381 | 11 Jun, 2025 | |
| Ron Frieson | 129,500 | 11 Jun, 2025 | |
| Leanne M Zumwalt | 109,400 | 11 Jun, 2025 | |
| Michael Thomas Heffernan | 48,586 | 03 Jun, 2021 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 02 Feb, 2026 | John P. Butler | Common Stock | D | 83,689 | $1.39 | 3,297,794 | D | S |
| 02 Feb, 2026 | John P. Butler | Common Stock | A | 175,250 | $1.41 | 3,381,483 | D | A |
| 02 Feb, 2026 | John P. Butler | Common Stock | D | 114,891 | $1.39 | 3,206,233 | D | S |
| 02 Feb, 2026 | John P. Butler | Common Stock | D | 46,660 | $1.39 | 3,417,189 | D | S |
| 02 Feb, 2026 | John P. Butler | Common Stock | D | 96,065 | $1.39 | 3,321,124 | D | S |
| 02 Feb, 2026 | Steven Keith Burke | Common Stock | D | 20,701 | $1.39 | 948,432 | D | S |
| 02 Feb, 2026 | Steven Keith Burke | Common Stock | D | 25,375 | $1.39 | 969,133 | D | S |
| 02 Feb, 2026 | Steven Keith Burke | Common Stock | D | 21,582 | $1.39 | 994,508 | D | S |
| 02 Feb, 2026 | Nicholas Grund | Common Stock | D | 53,585 | $1.39 | 592,994 | D | S |
| 02 Feb, 2026 | Nicholas Grund | Common Stock | D | 31,244 | $1.39 | 561,750 | D | S |
| 02 Feb, 2026 | Erik Ostrowski | Common Stock | D | 34,951 | $1.39 | 672,635 | D | S |
| 02 Feb, 2026 | Richard C Malabre | Common Stock | D | 36,142 | $1.39 | 312,772 | D | S |
| 02 Feb, 2026 | Richard C Malabre | Common Stock | D | 13,382 | $1.39 | 299,390 | D | S |
| 02 Feb, 2026 | Carolyn M. Rucci | Common Stock | D | 16,846 | $1.39 | 641,304 | D | S |
| 02 Feb, 2026 | Carolyn M. Rucci | Common Stock | D | 27,544 | $1.39 | 588,378 | D | S |
| 02 Feb, 2026 | Carolyn M. Rucci | Common Stock | D | 25,382 | $1.39 | 615,922 | D | S |
| 30 Jan, 2026 | John P. Butler | Common Stock | A | 743,000 | $0.00 | 3,463,849 | D | A |
| 30 Jan, 2026 | Steven Keith Burke | Common Stock | A | 204,000 | $0.00 | 1,016,090 | D | A |
| 30 Jan, 2026 | Nicholas Grund | Common Stock | A | 204,000 | $0.00 | 646,579 | D | A |
| 30 Jan, 2026 | Erik Ostrowski | Common Stock | A | 204,000 | $0.00 | 707,586 | D | A |